A collaboration between physicists and cardiologists at the University of California San Diego has resulted in an AI tool that can predict heart failure patients’ life expectancy with 88% accuracy.

Both the American College of Cardiology and the American Heart Association voiced their public support this week for legislation that would expand access to cardiac and pulmonary rehabilitation services in the U.S.

Taller people might be at an increased risk for atrial fibrillation, according to research set for presentation at the American Heart Association’s Scientific Sessions on Nov. 16.

Research out of Peking University in Beijing, China, has established a link between insomnia and heart disease, ABC News reports.

Millions of Americans are unaware of common heart attack symptoms, according to researchers, including a subset of 13.5 million people who admit to not knowing a single symptom of MI.

Research published in JAMA Nov. 12 suggests that, despite the Organ Procurement and Transplant Network’s overhaul of the U.S. heart allocation system in 2018, CV transplant programs still suffer from variability in survival benefit and a lack of standardized guidelines for ranking candidates.

The net clinical benefit of anticoagulants like warfarin and apixaban slows over time in patients with atrial fibrillation, according to a Circulation: Cardiovascular Quality and Outcomes study, diminishing as people age and face competing risks of death.

A Portland-area cardiologist has been accused of implanting more than 100 patients with unnecessary pacemakers, incentivized by free travel and gifts from device sales representatives, the East Oregonian reports.

The FDA issued a safety communication Nov. 5 reminding the public, healthcare providers and lab workers that the common supplement vitamin B7, or biotin, can interfere with certain diagnostic tests, including troponin tests that can be integral to a heart attack diagnosis.

Women face a greater risk of bleeding and hemorrhagic stroke after PCI than men, according to a new subgroup analysis of the GLOBAL LEADERS trial.